Literature DB >> 24337844

MicroRNA-34a regulates high glucose-induced apoptosis in H9c2 cardiomyocytes.

Fang Zhao1, Bo Li2, Yin-Zhi Wei3, Bin Zhou3, Han Wang3, Ming Chen3, Xue-Dong Gan3, Zhao-Hui Wang4, Shi-Xi Xiong3.   

Abstract

Hyperglycemia is an important initiator of cardiovascular disease, contributing to the development of cardiomyocyte death and diabetic complications. The purpose of the present study was to investigate whether high glucose state could induce apoptosis of rat cardiomyocyte cell line H9c2 through microRNA-mediated Bcl-2 signaling pathway. The expression of miR-34a and Bcl-2 mRNA was detected by using real-time PCR. Western blotting was used to examine the changes in apoptosis-associated protein Bcl-2. Apoptosis of H9c2 cells was tested by using flow cytometry. The results showed that the expression of miR-34a was significantly elevated and that of Bcl-2 was strongly reduced, and apoptosis of cardiomyocytes was apparently increased in the high-glucose-treated H9c2 cells as compared with normal-glucose-treated controls. In addition, we identified Bcl-2 gene was the target of miR-34a. miR-34a mimics reduced the expression of Bcl-2 and increased glucose-induced apoptosis, but miR-34a inhibitor acted as the opposite mediator. Our data demonstrate that miR-34a contributes to high glucose-induced decreases in Bcl-2 expression and subsequent cardiomyocyte apoptosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24337844     DOI: 10.1007/s11596-013-1207-7

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  31 in total

Review 1.  Toward transcriptional therapies for the failing heart: chemical screens to modulate genes.

Authors:  Timothy A McKinsey; Eric N Olson
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

Review 2.  MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets.

Authors:  Eva van Rooij; Eric N Olson
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

3.  Identification of tissue-specific microRNAs from mouse.

Authors:  Mariana Lagos-Quintana; Reinhard Rauhut; Abdullah Yalcin; Jutta Meyer; Winfried Lendeckel; Thomas Tuschl
Journal:  Curr Biol       Date:  2002-04-30       Impact factor: 10.834

4.  Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study.

Authors:  Lei Kong; Junjie Zhu; Wenxia Han; Xiuyun Jiang; Min Xu; Yue Zhao; Qiongzhu Dong; Zengfen Pang; Qingbo Guan; Ling Gao; Jiajun Zhao; Lei Zhao
Journal:  Acta Diabetol       Date:  2010-09-21       Impact factor: 4.280

5.  A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure.

Authors:  Eva van Rooij; Lillian B Sutherland; Ning Liu; Andrew H Williams; John McAnally; Robert D Gerard; James A Richardson; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-15       Impact factor: 11.205

6.  Intravenous gene therapy with PIM-1 via a cardiotropic viral vector halts the progression of diabetic cardiomyopathy through promotion of prosurvival signaling.

Authors:  Rajesh Katare; Andrea Caporali; Lorena Zentilin; Elisa Avolio; Graciela Sala-Newby; Atsuhiko Oikawa; Daniela Cesselli; Antonio Paolo Beltrami; Mauro Giacca; Costanza Emanueli; Paolo Madeddu
Journal:  Circ Res       Date:  2011-04-07       Impact factor: 17.367

Review 7.  Diabetic cardiomyopathy: experimental and clinical observations.

Authors:  T J Regan; S Ahmed; B Haider; C Moschos; A Weisse
Journal:  N J Med       Date:  1994-11

8.  MiR-34, SIRT1 and p53: the feedback loop.

Authors:  Munekazu Yamakuchi; Charles J Lowenstein
Journal:  Cell Cycle       Date:  2009-03-02       Impact factor: 4.534

9.  p53-mediated activation of miRNA34 candidate tumor-suppressor genes.

Authors:  Guido T Bommer; Isabelle Gerin; Ying Feng; Andrew J Kaczorowski; Rork Kuick; Robert E Love; Yali Zhai; Thomas J Giordano; Zhaohui S Qin; Bethany B Moore; Ormond A MacDougald; Kathleen R Cho; Eric R Fearon
Journal:  Curr Biol       Date:  2007-07-26       Impact factor: 10.834

10.  Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis.

Authors:  Tsung-Cheng Chang; Erik A Wentzel; Oliver A Kent; Kalyani Ramachandran; Michael Mullendore; Kwang Hyuck Lee; Georg Feldmann; Munekazu Yamakuchi; Marcella Ferlito; Charles J Lowenstein; Dan E Arking; Michael A Beer; Anirban Maitra; Joshua T Mendell
Journal:  Mol Cell       Date:  2007-05-31       Impact factor: 17.970

View more
  21 in total

Review 1.  Role of microRNA in diabetic cardiomyopathy: From mechanism to intervention.

Authors:  Rui Guo; Sreejayan Nair
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-03-24       Impact factor: 5.187

2.  Role of microRNAs in the pathogenesis of diabetic cardiomyopathy.

Authors:  Xinyu Liu; Shixue Liu
Journal:  Biomed Rep       Date:  2017-01-12

Review 3.  Relevance of mitochondrial dysfunction in heart disease associated with insulin resistance conditions.

Authors:  Natalia de Las Heras; Vicente Lahera
Journal:  Pflugers Arch       Date:  2021-11-22       Impact factor: 3.657

4.  High-Intensity Interval Training Improves Cardiac Function by miR-206 Dependent HSP60 Induction in Diabetic Rats.

Authors:  Maryam Delfan; Raheleh Amadeh Juybari; Sattar Gorgani-Firuzjaee; Jens Høiriis Nielsen; Neda Delfan; Ismail Laher; Ayoub Saeidi; Urs Granacher; Hassane Zouhal
Journal:  Front Cardiovasc Med       Date:  2022-06-29

5.  Effects of milrinone on inflammatory response-related gene expressions in cultured rat cardiomyocytes.

Authors:  Archana G Venakatesh; Johann J Mathew; Scott Coleman; Longqiu Yang; Geoffrey L Liu; Marilyn M Li; Henry Liu
Journal:  J Biomed Res       Date:  2018-11-18

Review 6.  Regulating microRNA expression: at the heart of diabetes mellitus and the mitochondrion.

Authors:  Quincy A Hathaway; Mark V Pinti; Andrya J Durr; Shanawar Waris; Danielle L Shepherd; John M Hollander
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-10-06       Impact factor: 4.733

7.  Transcriptomic studies revealed pathophysiological impact of COVID-19 to predominant health conditions.

Authors:  Zulkar Nain; Shital K Barman; Md Moinuddin Sheam; Shifath Bin Syed; Abdus Samad; Julian M W Quinn; Mohammad Minnatul Karim; Mahbubul Kabir Himel; Rajib Kanti Roy; Mohammad Ali Moni; Sudhangshu Kumar Biswas
Journal:  Brief Bioinform       Date:  2021-06-02       Impact factor: 11.622

8.  Identifying molecular insight of synergistic complexities for SARS-CoV-2 infection with pre-existing type 2 diabetes.

Authors:  M Babul Islam; Utpala Nanda Chowdhury; Zulkar Nain; Shahadat Uddin; Mohammad Boshir Ahmed; Mohammad Ali Moni
Journal:  Comput Biol Med       Date:  2021-07-23       Impact factor: 4.589

Review 9.  Overview of MicroRNAs in Cardiac Hypertrophy, Fibrosis, and Apoptosis.

Authors:  Juan Wang; Oi Wah Liew; Arthur Mark Richards; Yei-Tsung Chen
Journal:  Int J Mol Sci       Date:  2016-05-18       Impact factor: 5.923

Review 10.  Subclinical Detection of Diabetic Cardiomyopathy with MicroRNAs: Challenges and Perspectives.

Authors:  Luis E León; Sweta Rani; Mauricio Fernandez; Martín Larico; Sebastián D Calligaris
Journal:  J Diabetes Res       Date:  2015-12-06       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.